Clinical Pharmacology Quality Assurance (CPQA)

NIAID临床药理学质量保证（CPQA）计划的目的是为临床药理学实验室检测NIAID支持的临床研究受试者的样本提供一个全面的质量评估计划。CPQA计划通过向实验室提供药理学熟练度测试和分析控制的材料，并监控每个实验室的熟练度和分析数据，确保药理学研究数据的有效性和实验室间和实验室内的可比性。该计划还开发和实施新的药理学分析的性能标准，开发和测试与分析相关的方法，并获取，测试，储存和分配质量控制材料和试剂。因此，CPQA计划对于正在进行的和未来的有关艾滋病毒和其他传染病的治疗和预防措施评估的研究的科学完整性至关重要。

The purpose of NIAID Clinical Pharmacology Quality Assurance (CPQA) Program is to provide a comprehensive quality assessment program for clinical pharmacologic laboratories testing samples from subjects enrolled in NIAID-supported clinical studies. The CPQA Program ensures the validity and inter- and intra-laboratory comparability of pharmacological study data by providing laboratories with materials for pharmacology proficiency testing and assay controls, and monitoring proficiency and assay data from each laboratory. The program also develops and implements standards of performance for new pharmacology assays, develops and tests methods relating to the assays, and acquires, tests, stores, and dispenses quality control materials and reagents. Thus, the CPQA Program is critical to the scientific integrity of on-going and future studies concerning the assessment of therapeutic and prevention measures for HIV and other infectious diseases.